Works matching AU Scheen, Andre

Results: 127

Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide.

Published in:

2007

By:

Scheen, André J.;
Scheen, André J

Publication type:

journal article

Pharmacokinetic interactions with thiazolidinediones.

Published in:

2007

By:

Scheen, André J.;
Scheen, André J

Publication type:

journal article

Drug interactions of clinical importance with antihyperglycaemic agents: an update.

Published in:

2005

By:

Scheen, André J.;
Scheen, André J

Publication type:

journal article

Diabetes is still a risk factor for restenosis after drug-eluting stent in coronary arteries.

Published in:

2004

By:

Scheen, Andre J.;
Warzée, Fabian;
Scheen, André J;
Warzée, Fabian

Publication type:

commentary

Pharmacokinetic Characteristics and Clinical Efficacy of an SGLT2 Inhibitor Plus DPP-4 Inhibitor Combination Therapy in Type 2 Diabetes.

Published in:

2017

By:

Scheen, André;
Scheen, André J

Publication type:

journal article

Discrepancies between the Cockcroft-Gault and Chronic Kidney Disease Epidemiology (CKD-EPI) Equations: Implications for Refining Drug Dosage Adjustment Strategies.

Published in:

2017

By:

Delanaye, Pierre;
Guerber, Fabrice;
Scheen, André;
Ellam, Timothy;
Bouquegneau, Antoine;
Guergour, Dorra;
Mariat, Christophe;
Pottel, Hans;
Scheen, André

Publication type:

journal article

Squatting test: a dynamic postural manoeuvre to study baroreflex sensitivity.

Published in:

Clinical Autonomic Research, 2012, v. 22, n. 1, p. 35, doi. 10.1007/s10286-011-0140-8

By:

Scheen, André;
Philips, Jean-Christophe

Publication type:

Article

Sodium–glucose cotransporter 2 inhibitors: renal outcomes according to baseline albuminuria.

Published in:

Clinical Kidney Journal, 2021, v. 14, n. 12, p. 2463, doi. 10.1093/ckj/sfab096

By:

Delanaye, Pierre;
Wissing, Karl Martin;
Scheen, Andre J

Publication type:

Article

Canagliflozin: A Review in Type 2 Diabetes.

Published in:

Drugs, 2017, v. 77, n. 14, p. 1577, doi. 10.1007/s40265-017-0801-6

By:

Scheen, André;
Deeks, Emma

Publication type:

Article

Pharmacodynamics, Efficacy and Safety of Sodium-Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus.

Published in:

2015

By:

Scheen, André

Publication type:

Journal Article

Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.

Published in:

Bipolar Disorders, 2008, v. 10, n. 2, p. 342, doi. 10.1111/j.1399-5618.2007.00520.x

By:

Van Winkel, Ruud;
De Hert, Marc;
Van Eyck, Dominique;
Hanssens, Linda;
Wampers, Martien;
Scheen, Andre;
Peuskens, Joseph

Publication type:

Article

Relation between Disease Phenotype and HLA-DQ Genotype in Diabetic Patients Diagnosed in Early Adulthood.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 6, p. 2597, doi. 10.1210/jcem.87.6.8613

By:

WEETS, ILSE;
SIRAUX, VALERIE;
DAUBRESSE, JEAN-CLAUDE;
DE LEEUW, IVO H.;
FÉRY, FRANCOISE;
KEYMEULEN, BART;
KRZENTOWSKI, GEORGES;
LETIEXHE, MICHEL;
MATHIEU, CHANTAL;
NOBELS, FRANK;
ROTTIERS, RAOUL;
SCHEEN, ANDRÉ;
VAN GAAL, LUC;
SCHUIT, FRANS C.;
VAN DER AUWERA, BART;
MAO RUI;
DE PAUW, PIETER;
KAUFMAN, LEONARD;
GORU, FRANS K.

Publication type:

Article

No Increased Insulin Sensitivity after a Single Intravenous Administration of a Recombinant Human Tumor Necrosis Factor Receptor: Fc Fusion Protein in Obese Insulin-Resistant Patients.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 3, p. 1316, doi. 10.1210/jcem.85.3.6417

By:

PAQUOT, NICOLAS;
CASTILLO, MANUEL J.;
LEFÈBVRE, PIERRE J.;
SCHEEN, ANDRE J.

Publication type:

Article

Parallel Reversibility of Biological Markers of the Metabolic Syndrome and Liver Steatosis after Gastroplasty-Induced Weight Loss in Severe Obesity.

Published in:

Journal of Clinical Endocrinology & Metabolism, 1999, v. 84, n. 11, p. 4293, doi. 10.1210/jcem.84.11.6171-4

By:

Luyckx, Françoise H.;
Scheen, André J.;
Desaive, Claude;
Thiry, Albert;
Lefébvre, Pierre J.

Publication type:

Article

When therapeutic drugs lead to diabetes.

Published in:

Diabetologia, 2022, v. 65, n. 5, p. 751, doi. 10.1007/s00125-022-05666-w

By:

Fève, Bruno;
Scheen, André J.

Publication type:

Article

Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue.

Published in:

Diabetologia, 2013, v. 56, n. 11, p. 2487, doi. 10.1007/s00125-013-3023-9

By:

Esser, Nathalie;
L'homme, Laurent;
Roover, Arnaud;
Kohnen, Laurent;
Scheen, André;
Moutschen, Michel;
Piette, Jacques;
Legrand-Poels, Sylvie;
Paquot, Nicolas

Publication type:

Article

Devices for the Treatment of Diabetes: Today.

Published in:

Artificial Organs, 1992, v. 16, n. 2, p. 163, doi. 10.1111/j.1525-1594.1992.tb00287.x

By:

Scheen, Andre J.

Publication type:

Article

Factors associated with clinical inertia: an integrative review.

Published in:

Advances in Medical Education & Practice, 2014, v. 5, p. 141, doi. 10.2147/AMEP.S59022

By:

Aujoulat, Isabelle;
Jacquemin, Patricia;
Rietzschel, Ernst;
Scheen, André;
Tréfois, Patrick;
Wens, Johan;
Darras, Elisabeth;
Hermans, Michel P.

Publication type:

Article

Insulin detemir in the treatment of type 1 and type 2 diabetes.

Published in:

2006

By:

Philips, Jean-Christophe;
Scheen, André

Publication type:

journal article

Aspirin and clopidogrel resistance in patients with diabetes mellitus.

Published in:

European Heart Journal, 2006, v. 27, n. 23, p. 2900, doi. 10.1093/eurheartj/ehl295

By:

Scheen, André J.;
Legrand, Delphine

Publication type:

Article

Drug-eluting stents: meta-analysis in diabetic patients.

Published in:

European Heart Journal, 2004, v. 25, n. 23, p. 2167, doi. 10.1016/j.ehj.2004.07.041

By:

Scheen, André J.;
Warzée, Fabian;
Legrand, Victor M.G.

Publication type:

Article

Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.

Published in:

1987

By:

Paolisso, Giuseppe;
Sgambato, Saverio;
Passariello, Nicola;
Scheen, André;
D'Onofrio, Felice;
Lefèbvre, Pierre J.;
Paolisso, G;
Sgambato, S;
Passariello, N;
Scheen, A;
D'Onofrio, F;
Lefèbvre, P J

Publication type:

journal article

Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus.

Published in:

Diabetes/Metabolism Research & Reviews, 2010, v. 26, n. 7, p. 540, doi. 10.1002/dmrr.1114

By:

Scheen, André J.;
Charpentier, Guillaume;
Östgren, Carl Johan;
Hellqvist, Åsa;
Gause-Nilsson, Ingrid

Publication type:

Article

Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.

Published in:

Diabetes/Metabolism Research & Reviews, 2004, v. 20, n. 3, p. 178, doi. 10.1002/dmrr.447

By:

Radermecker, Régis Pierre;
Scheen, André Jacques

Publication type:

Article

Antiobesity pharmacotherapy in the management of type 2 diabetes.

Published in:

2000

By:

Scheen, André J.;
Lefèbvre, Pierre J.;
Scheen, A J;
Lefèbvre, P J

Publication type:

journal article

Careful use to minimize adverse events of oral antidiabetic medications in the elderly.

Published in:

Expert Opinion on Pharmacotherapy, 2021, v. 22, n. 16, p. 2149, doi. 10.1080/14656566.2021.1912735

By:

Scheen, André J.

Publication type:

Article

Preventing and treating kidney disease in patients with type 2 diabetes.

Published in:

Expert Opinion on Pharmacotherapy, 2019, v. 20, n. 3, p. 277, doi. 10.1080/14656566.2018.1551362

By:

Delanaye, Pierre;
Scheen, André J.

Publication type:

Article

Pharmacotherapy of ‘treatment resistant’ type 2 diabetes.

Published in:

Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 5, p. 503, doi. 10.1080/14656566.2017.1297424

By:

Scheen, André J.

Publication type:

Article

Will delayed release metformin provide better management of diabetes type 2?

Published in:

2016

By:

Scheen, André J.

Publication type:

Editorial

Foreword.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2000, v. 24, p. S1, doi. 10.1038/sj.ijo.0801322

By:

Van Gaal, Luc F;
Scheen, Andre J

Publication type:

Article

Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents.

Published in:

2002

By:

Scheen, André J;
Lefèbvre, Pierrè J

Publication type:

commentary

Potential Pharmacokinetics Interference Between α-Glucosidase Inhibitors and Other Oral Antidiabetic Agents.

Published in:

Diabetes Care, 2002, v. 25, n. 1, p. 247, doi. 10.2337/diacare.25.1.247

By:

Scheen, Andre J.;
Lefebvre, Pierre J.

Publication type:

Article

Troglitazone: Antihyperglycemic Activity and Potential Role in the Treatment of Type 2 Diabetes.

Published in:

Diabetes Care, 1999, v. 22, n. 9, p. 1568, doi. 10.2337/diacare.22.9.1568

By:

Scheen, Andre J.;
Lefebvre, Pierre J.

Publication type:

Article

Detection of early sympathetic cardiovascular neuropathy by squatting test in NIDDM.

Published in:

1994

By:

Marfella, Raffaele;
Salvatore, Teresa;
Giugliano, Dario;
Di Maro, Glosue;
Giunta, Riccardo;
Torella, Roberto;
Juchmes, Jacques;
Scheen, Andre;
Lefebvre, Pierre J.;
Marfella, R;
Salvatore, T;
Giugliano, D;
Di Maro, G;
Giunta, R;
Torella, R;
Juchmes, J;
Scheen, A;
Lefebvre, P J

Publication type:

journal article

Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine.

Published in:

1991

By:

Scheen, André J.;
Paolisso, Giuseppe;
Salvatore, Teresa;
Lefèbvre, Pierre J.;
Scheen, A J;
Paolisso, G;
Salvatore, T;
Lefèbvre, P J

Publication type:

journal article

Decreased or increased insulin metabolism after glipizide in type II diabetes.

Published in:

1988

By:

Scheen, André J;
Castillo, Manuel J.;
Lefèbvre, Pierre J.;
Scheen, A J;
Castillo, M J;
Lefèbvre, P J

Publication type:

Letter

U-100 insulin gives some protection against metabolic deterioration due to CSII interruption.

Published in:

1987

By:

Scheen, André J.;
Henrivaux, Philippe;
Jandrain, Bernard;
Lefèbvre, Pierre J.;
Scheen, A J;
Henrivaux, P;
Jandrain, B;
Lefèbvre, P J

Publication type:

journal article

Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII.

Published in:

1987

By:

Scheen, André J.;
Henrivaux, Philippe;
Jandrain, Bernard;
Paolisso, Giuseppe;
Lefebvre, Pierre J.;
Scheen, A J;
Henrivaux, P;
Jandrain, B;
Paolisso, G;
Lefèbvre, P J

Publication type:

journal article

Lack of systematic metabolic alterations after a one-hour interruption of continuous subcutaneous insulin infusion in type I diabetic patients.

Published in:

1985

By:

Scheen, André;
Henrivaux, Philippe;
Jandrain, Bernard;
Luyckx, Alfred S.;
Lefebvre, Pierre J.;
Scheen, A;
Henrivaux, P;
Jandrain, B;
Luyckx, A S;
Lefebvre, P J

Publication type:

journal article

Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion.

Published in:

1984

By:

Scheen, André;
Castillo, Manuel;
Jandrain, Bernard;
Krzentowski, Georges;
Henrivaux, Philippe;
Luyckx, Alfred S.;
Lefebvre, Pierre J.;
Scheen, A;
Castillo, M;
Jandrain, B;
Krzentowski, G;
Henrivaux, P;
Luyckx, A S;
Lefèbvre, P J

Publication type:

journal article

Hepatic Insulin Resistance in Obese Non-Diabetic Subjects and in Type 2 Diabetic Patients.

Published in:

Obesity (19307381), 2002, v. 10, n. 3, p. 129, doi. 10.1038/oby.2002.21

By:

Paquot, Nicolas;
Scheen, André J.;
Dirlewanger, Mirjam;
Lefèbvre, Pierre J.;
Tappy, Luc

Publication type:

Article

Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System.

Published in:

Drugs, 2004, v. 64, n. 22, p. 2537, doi. 10.2165/00003495-200464220-00004

By:

Scheen, André J.

Publication type:

Article

Current Management Strategies for Coexisting Diabetes Mellitus and Obesity.

Published in:

Drugs, 2003, v. 63, n. 12, p. 1165, doi. 10.2165/00003495-200363120-00001

By:

Scheen, Andre J.

Publication type:

Article

Is There a Role for α-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?

Published in:

Drugs, 2003, v. 63, n. 10, p. 933, doi. 10.2165/00003495-200363100-00002

By:

Scheen, André J.

Publication type:

Article

Effect of brivaracetam on CYP3A activity, measured by oral midazolam.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 5, p. 543, doi. 10.1002/jcph.446

By:

Stockis, Armel;
Watanabe, Shikiko;
Scheen, André J.

Publication type:

Article

The safety of gliptins : updated data in 2018.

Published in:

Expert Opinion on Drug Safety, 2018, v. 17, n. 4, p. 387, doi. 10.1080/14740338.2018.1444027

By:

Scheen, André Jacques

Publication type:

Article

Pharmacokinetic, toxicological, and clinical considerations for the treatment of type 2 diabetes in patients with liver disease: a comprehensive update.

Published in:

Expert Opinion on Drug Metabolism & Toxicology, 2023, v. 19, n. 8, p. 543, doi. 10.1080/17425255.2023.2252333

By:

Scheen, André J.

Publication type:

Article

Counteracting heart failure with diabetes drugs: a review into the pharmacokinetic and pharmacodynamic properties.

Published in:

Expert Opinion on Drug Metabolism & Toxicology, 2022, v. 18, n. 6, p. 381, doi. 10.1080/17425255.2022.2105693

By:

Scheen, André J.

Publication type:

Article

Pharmacokinetic drug evaluation of saxagliptin plus dapagliflozin for the treatment of type 2 diabetes.

Published in:

Expert Opinion on Drug Metabolism & Toxicology, 2017, v. 13, n. 5, p. 583, doi. 10.1080/17425255.2017.1315102

By:

Scheen, André J.

Publication type:

Article

DPP-4 inhibitor plus SGLT-2 inhibitor as combination therapy for type 2 diabetes: from rationale to clinical aspects.

Published in:

Expert Opinion on Drug Metabolism & Toxicology, 2016, v. 12, n. 12, p. 1407, doi. 10.1080/17425255.2016.1215427

By:

Scheen, André J.

Publication type:

Article